Danaparoid and haemorrhagic diathesis Patient Reports February 12, 2012

Danaparoid Side Effects Report #4976157-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, condition aggravated, gastrointestinal haemorrhage, haemorrhagic diathesis, hyperkalaemia, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4995842-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous, haemorrhagic diathesis, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5050457-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhagic diathesis. Danaparoid dosage: unknown. During the same period patient was treated with CEFPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.

Danaparoid Side Effects Report #5051299-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gallbladder disorder, haemoglobin decreased, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.


Danaparoid Side Effects Report #5076374-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 27, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.

Danaparoid Side Effects Report #5051297-9
Danaparoid side effect was reported by a Health Professional from JAPAN on July 04, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haemoglobin decreased, haemorrhage, haemorrhagic diathesis, henoch-schonlein purpura, renal disorder, staphylococcal infection . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, WARFARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5116970-2
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 15, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhagic diathesis, henoch-schonlein purpura, renal disorder, staphylococcal infection . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, WARFARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5121583-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematoma, haemorrhagic diathesis, henoch-schonlein purpura, hepatic function abnormal, renal disorder, staphylococcal infection . Danaparoid dosage: unknown. During the same period patient was treated with ENOXAPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, HEPARIN, WARFARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5051298-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 03, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: depressed level of consciousness, haemorrhagic diathesis, pancytopenia, subarachnoid haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, MEROPENEM, FLUCONAZOLE, IMMUNE GLOBULIN INTRAVENOUS, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, TOBRAMYCIN, NAFAMOSTAT MESILATE. Patient died.


Danaparoid Side Effects Report #5121584-4
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 19, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: depressed level of consciousness, haemorrhagic diathesis, pancytopenia, subarachnoid haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, MEROPENEM, FLUCONAZOLE, IMMUNE GLOBULIN INTRAVENOUS, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, TOBRAMYCIN, NAFAMOSTAT MESILATE. Patient died.